Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exubera vs Humalog in Type 1 Diabetes
NCT00356421Phase 4Terminated
- Sponsor
- Pfizer
- Start
- Nov 2006
- Primary completion
- Jun 2008
- Modality
- Biologic
- Countries
- 13
01
Overview
Phase 4, randomised, open-label trial of insulin human in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Pfizer. Primary endpoint: Change From Baseline in Glycosylated Hemoglobin (HbA1c) at 52 weeks. Started Nov 2006; status: terminated.
02
Drugs
insulin human
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00356421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00356421.